<DOC>
	<DOC>NCT00829296</DOC>
	<brief_summary>The study is being done to see if a drug shown to lower the risk of heart failure is also effective in reducing the stiffness of the arteries.</brief_summary>
	<brief_title>Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries</brief_title>
	<detailed_description>To determine the effect of nebivolol versus metoprolol in Type 2 hypertensive diabetic patients on systolic blood pressure and diastolic blood pressure.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Established Type 2 diabetic not treated with insulin Stage 1 hypertensives blood pressure &gt; 130/80 mmHg and &lt; 160/100 mmHg BMI &lt; 35 Hemoglobin A1C &lt; 8.5 Must be postmenopausal or taking some form of birth control of surgically sterile Acute myocardial infarction, unstable angina, stroke or TIA within the past year. Active angina in the last three months Diabetes requiring treatment with insulin Severe asthma Female who are pregnant, planning to be pregnant during the study period, lactating or women of childbearing potential who are not using a medically approved method of contraception Recent history of substance or alcohol abuse . Uncontrolled hypertension systolic blood pressure &gt;160mmHg or diastolic blood pressure &gt; 100 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>diabetes</keyword>
	<keyword>hypertension</keyword>
	<keyword>aortic impedance</keyword>
</DOC>